Table 9.
Key performance indicators of ischaemic stroke from Chinese Stroke Center Alliance in 2019
| Key performance indicators | Total | Male | Female | |||
| Relative frequency | % (95% CI) | Relative frequency | % (95% CI) | Relative frequency | % (95% CI) | |
| Acute performance measures | ||||||
| Intravenous rtPA ≤4.5 hours | 22 264/76 067 | 29.3 (29.0 to 29.6) |
14 362/47653 | 30.1 (29.7 to 30.6) | 7901/28 413 | 27.8 (27.3 to 28.3) |
| Early antithrombotics | 248 732/288 789 | 86.1 (86.0 to 86.3) |
156 305/181 046 | 86.3 (86.2 to 86.5) | 92 426/107 740 | 85.8 (85.6 to 86.0) |
| DVT prophylaxis | 13 295/81 950 | 16.2 (16.0 to 16.5) |
7283/48 175 | 15.1 (14.8 to 15.4) | 6012/33 773 | 17.8 (17.4 to 18.2) |
| Dysphagia screen | 243 149/294 573 | 82.5 (82.4 to 82.7) |
152 360/184 417 | 82.6 (82.4 to 82.8) | 90 787/110 153 | 82.4 (82.2 to 82.6) |
| Rehabilitation | 217 702/294 573 | 73.9 (73.8 to 74.1) |
136 012/184 417 | 73.8 (73.6 to 74.0) | 81 689/110 153 | 74.2 (73.9 to 74.4) |
| Discharge performance measures | ||||||
| Antithrombotics | 253 491/285 991 | 88.6 (88.5 to 88.8) |
159 668/179381 | 89.0 (88.9 to 89.2) | 93 822/106 607 | 88.0 (87.8 to 88.2) |
| Anticoagulants for AF | 9309/20 038 | 46.5 (45.8 to 47.2) |
4911/10 502 | 46.8 (45.8 to 47.7) | 4398/9536 | 46.1 (45.1 to 47.1) |
| BP lowering for HTN | 144 663/222 838 | 64.9 (64.7 to 65.1) |
88 283/137 385 | 64.3 (64.0 to 64.5) | 56 380/85 451 | 66.0 (65.7 to 66.3) |
| Glucose-lowering for hyperglycaemic | 64 290/82 053 | 78.4 (78.1 to 78.6) |
37 252/47 777 | 78.0 (77.6 to 78.3) | 27 038/34 276 | 78.9 (78.5 to 79.3) |
| Statin for LDL ≤100 or ND | 263 825/291503 | 90.5 (90.4 to 90.6) |
165 521/182584 | 90.7 (90.5 to 90.8) | 98 303/108 916 | 90.3 (90.1 to 90.4) |
| Smoking cessation | 66 744/69 234 | 96.4 (96.3 to 96.5) |
64 013/66 246 | 96.6 (96.5 to 96.8) | 2731/2988 | 91.4 (90.4 to 92.4) |
| Summary performance measures | ||||||
| Composite score | 0.78±0.20 | 0.78±0.20 | 0.77±0.21 | |||
| All-or-none measure | 75 240/294 573 | 25.5 (25.4 to 25.7) | 48 008/184 417 | 26.0 (25.8 to 26.2) | 27 232/110 153 | 24.7 (24.5 to 25.0) |
AF, atrial fibrillation; BP, blood pressure; DVT, deep vein thrombosis; HTN, hypertension; LDL, low-density lipoprotein; rtPA, recombinant tissue plasminogen activator.